Mount Yale Investment Advisors, LLC - TRANSMEDICS GROUP INC ownership

TRANSMEDICS GROUP INC's ticker is TMDX and the CUSIP is 89377M109. A total of 222 filers reported holding TRANSMEDICS GROUP INC in Q3 2023. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.

Quarter-by-quarter ownership
Mount Yale Investment Advisors, LLC ownership history of TRANSMEDICS GROUP INC
ValueSharesWeighting
Q3 2023$640,520
-34.1%
11,699
+1.0%
0.07%
-32.0%
Q2 2023$972,488
+150.4%
11,580
+125.8%
0.10%
+134.1%
Q1 2023$388,419
+91.6%
5,129
+56.1%
0.04%
+91.3%
Q4 2022$202,7503,2850.02%
Other shareholders
TRANSMEDICS GROUP INC shareholders Q3 2023
NameSharesValueWeighting ↓
Roubaix Capital, LLC 264,438$5,027,0004.84%
Abrams Capital Management 3,499,859$66,532,0002.07%
Sandhill Capital Partners LLC 736,175$13,995,0001.55%
EMERALD ADVISERS, LLC 451,542$8,584,0000.36%
RTW INVESTMENTS, LP 503,266$9,567,0000.36%
EMERALD MUTUAL FUND ADVISERS TRUST 429,868$8,172,0000.33%
NEXT CENTURY GROWTH INVESTORS LLC 107,045$2,034,0000.26%
ELEMENT CAPITAL MANAGEMENT LLC 63,175$1,201,0000.26%
HAMILTON LANE ADVISORS LLC 19,364$368,0000.16%
Harbour Capital Advisors, LLC 20,900$397,0000.15%
View complete list of TRANSMEDICS GROUP INC shareholders